(Total Views: 430)
Posted On: 08/25/2022 7:21:46 PM
Post# of 36566
The main hope outside of what they do concerning Generex, is what any of them do or some company does with NGIO.
NGIO is really the billion dollar question in all of this. The technology that is there, the 10 year study, the work in Keytruda, the appraisal, everything combined with NGIO.
If NGIO got bought or listed, everything changes for everyone. Generex now is just a piece of the puzzle that no one has any clue about thanks to a management team that was supposed to be supporting shareholders and left them holding nothing.
NGIO is really the billion dollar question in all of this. The technology that is there, the 10 year study, the work in Keytruda, the appraisal, everything combined with NGIO.
If NGIO got bought or listed, everything changes for everyone. Generex now is just a piece of the puzzle that no one has any clue about thanks to a management team that was supposed to be supporting shareholders and left them holding nothing.
(0)
(0)
